Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01085019
Other study ID # INAF-2009-253
Secondary ID
Status Completed
Phase N/A
First received March 9, 2010
Last updated June 26, 2012
Start date March 2010
Est. completion date December 2011

Study information

Verified date June 2012
Source Laval University
Contact n/a
Is FDA regulated No
Health authority Canada: Health Canada
Study type Interventional

Clinical Trial Summary

The general objective of the study is to investigate the effects of the daily consumption of spices and herbs for four (4) consecutive weeks in endothelial function and cardiovascular risk factors of men and postmenopausal women.


Description:

The purpose is to assess whether the polyphenol/antioxidant content of different spices will affect endothelial function and other cardiovascular risk factors.


Recruitment information / eligibility

Status Completed
Enrollment 224
Est. completion date December 2011
Est. primary completion date June 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Age 40-70 yrs

- Men and postmenopausal women

- Waist girth >102cm (men) or >88cm (women)

- LDL-C > 2.8 mmol/L

- Framingham 10-yr risk score < 10%

- Marginal endothelial dysfunction

- Non smoker

Exclusion Criteria:

- Medication for lipid, hypertension, diabetes

- History of CVD, diabetes, other endocrines disorders

- Pre-menopausal women

- Alcohol consumption > 1 drink per day

- Unusual dietary habits (e.g. vegetarism)

- Chronic use of supplements (estrogens, vitamins, minerals or flavonoids)

- Aversion or intolerance for spices and/or herbs

- Injury to fingers or amrs that would interfere with endothelial function measurement

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Prevention


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Cinnamon
2.8g/day of cinnamon in capsules during 4 weeks.
Oregano
2.8g/day of oregano in capsules during 4 weeks.
Ginger
2.8g/day of ginger in capsules during 4 weeks.
Rosemary
2.8g/day of rosemary in capsules during 4 weeks.
Black pepper
2.8g/day of black pepper in capsules for 4 weeks.
Placebo
2.8 g/day of placebo in capsules (corn starch) during 4 weeks.

Locations

Country Name City State
Canada Institute of Nutraceuticals and Functional Foods Quebec City Quebec
Canada Richardson Centre of Functional Foods and Nutracuticals Winnipeg Manitoba

Sponsors (2)

Lead Sponsor Collaborator
Laval University McCormick Canada Co

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Endothelial function measured by endopat system (the endothelium-mediated changes in vacular tone) at week 0 and week 4 No
Secondary Circulating level of plasma lipoproteins-lipids at week 0 and week 4 No
Secondary Oxidative stress at week 0 and week 4 No
Secondary Endothelial activation and inflammatory markers at week 0 and week 4 No
See also
  Status Clinical Trial Phase
Completed NCT03301402 - Air Purifier to Improve Endothelial Function and Carotid Intima Thickness N/A
Recruiting NCT02500329 - Effect of Gemigliptin or Acarbose on Endothelial Function in Type 2 DM Patients Phase 4
Completed NCT01947790 - Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease Phase 4
Completed NCT01028599 - Effect of Physical Training on Oxygen Uptake and Endothelial Function in Heart Transplant Recipients N/A
Completed NCT00575120 - Endothelial Function Assessed With BOLD-MRI N/A
Active, not recruiting NCT05451641 - Blood Flow Restriction Resistance Training Intervention on Vascular Function N/A
Completed NCT01713374 - Physiological Assessment of the Endothelium - Circadian Rhythm and Role of the Sympathetic Nervous System N/A
Completed NCT03651713 - Hyperglycemia, Exercise, and Endothelial Function N/A
Completed NCT00844714 - Cardiovascular Risk Markers in Patients With Rheumatoid Arthritis: Effect of Rituximab Therapy N/A
Completed NCT01256957 - Effect of HEPA Air Filters on Subclinical Markers of Cardiovascular Health N/A
Completed NCT00967252 - Impact of Chronic Statin Use During Surgery on Inflammation and Infection Rates N/A
Completed NCT00728221 - Evaluation and Standardization of Ginseng and it's Components for Blood Pressure Regulation Phase 2
Completed NCT00845013 - Epidemiology and Pathogenesis of HIV-Associated Pulmonary Hypertension
Completed NCT00534651 - Paracetamol and Endothelial Function in Patients With Stable Coronary Artery Disease Phase 4
Recruiting NCT04689477 - Non-invasive Characterization of Systemic Microvascular Reactivity by Near-infrared Diffuse Optical Spectroscopy in COVID-19 Patients
Completed NCT01829542 - Dose-dependent Effects of Blueberry Polyphenols on Endothelial Function in Healthy Individuals N/A
Completed NCT01610401 - The Metformin-FMD Trial Phase 4
Terminated NCT00942643 - Endothelial Damage and Atherosclerosis in Obstructive Sleep Apnea N/A
Completed NCT05235958 - VascuFit: Exercise and Vascular Aging N/A
Not yet recruiting NCT06288828 - The Efficacy of Aerobic Exercise Training on Autonomic Nervous System and Endothelial Function in Patients With Compensated Cirrhosis N/A